RxDoctor Payments Data

Ryanne Waage, PA

Physician Assistant · Aberdeen, SDNPI 1871896431

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.2% of the total across 529 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,149in general payments, 2019–2025

Across 529 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$1K
  • Novartis$1K
  • Regeneron Healthcare Solutions, Inc.$864
  • Sanofi$739
  • plus $3K from 14 others

What the payments were for

  • Food & beverage$8,43392%
  • Education$7168%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,149 in reported general payments places this provider in the 95th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$485,281
Medicare patients
1,145
Services billed
7,580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab71$262,365
Cosentyx Unoready PenSecukinumab15$151,157
Cosentyx Sensoready (2 Pens)Secukinumab14$103,581
Tacrolimus30$6,161
Betamethasone Dipropionate121$5,595
Fluorouracil42$3,801
Ketoconazole68$2,928
Imiquimod114$2,225
Fluocinonide43$2,153
Clobetasol Propionate22$1,371
Doxycycline Hyclate68$1,242
Clindamycin Phosphate26$1,179
Dapsone14$940
CiclopiroxCiclopirox Olamine37$727
Metronidazole11$642

Paid to pharmacies, not to this prescriber.

Other physician assistant in Aberdeen

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →